Shopping Cart
- Remove All
Your shopping cart is currently empty
GNF2133 hydrochloride is a selective, effective, and orally active DYRK1A inhibitor, able to act on DYRK1A (IC50: 0.0062 μM) and GSK3β (IC50> 50 μM); GNF2133 hydrochloride showed good proliferative ability and efficacy in rat and human primary β cells. GNF2133 hydrochloride significantly improved glucose processing ability and increased insulin secretion. GNF2133 hydrochloride has the potential to study type 1 diabetes.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,530 | 1-2 weeks | |
| 50 mg | $1,990 | 1-2 weeks | |
| 100 mg | $3,230 | 1-2 weeks |
| Description | GNF2133 hydrochloride is a selective, effective, and orally active DYRK1A inhibitor, able to act on DYRK1A (IC50: 0.0062 μM) and GSK3β (IC50> 50 μM); GNF2133 hydrochloride showed good proliferative ability and efficacy in rat and human primary β cells. GNF2133 hydrochloride significantly improved glucose processing ability and increased insulin secretion. GNF2133 hydrochloride has the potential to study type 1 diabetes. |
| Targets&IC50 | DYRK1A:0.0062 μM, GSK-3β:>50 μM |
| Molecular Weight | 471.0 |
| Formula | C24H31ClN6O2 |
| Cas No. | 2561414-57-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.